Skip to content

NantHealth, Inc.

Delisted

CIK 1566469fmd_0E5A1K2YWN0Y0C0NRHNRVMW72TServices · Services-Computer Processing & Data PreparationTemplate: Standard

Coverage: Jan 01, 2014 to Sep 30, 2023, 36 periods

Income Statement · Annual · Millions · USD
Line itemFY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022
Total revenues344680878977736367
Cost of revenue242144424434292829
Gross profit102536454543443538
Realized investment gains (losses)(0)(4)(0)0–––––
Research and development171447342114172023
Selling, general and administrative4656105757156495263
Total operating expenses94701571139678707689
Operating income(85)(44)(120)(68)(51)(34)(26)(41)(51)
Other non-operating income (expense)(0)241(18)(6)(11)(3)(3)
Income before taxes(85)(45)(164)(134)(194)(66)(88)(58)(68)
Income tax expense00(24)(2)(4)(1)00(0)
Net income from continuing operations(85)(46)(141)(131)(190)(65)(88)(59)(68)
Net income(84)(72)(184)(175)(192)(63)(56)(58)(68)
Net income to common shareholders(84)(88)(189)(175)(192)––––
NantHealth, Inc. financial statements · FinancialMD